Physician profile
Thomas N Bustros
NPI 1144409269
$3,456.09
in general payments reported to CMS, 2019-2025
26 companies · $898 in 2025
The $898 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $141 · 2020: $30.83 · 2021: $94.60 · 2022: $393 · 2023: $1,153 · 2024: $746 · 2025: $898.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,797.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,797.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cvrx, INC. | $706.02 | 2022-2023 | Barostim Neo System |
| Kestra Medical Technology Services, INC. | $624.22 | 2025 | Assure Wcd |
| Abbott Laboratories | $314.79 | 2019-2025 | Cardiomems, Thoratec Heartmate 3 Lvas Implant Kit |
| Scpharmaceuticals INC. | $297.81 | 2024 | |
| Novartis Pharmaceuticals Corporation | $211.86 | 2020-2024 | |
| Medtronic, INC. | $182.73 | 2022-2024 | Linq II, Mycarelink |
| Impulse Dynamics (USA) INC. | $167.56 | 2023 | Optimizer |
| Pfizer INC. | $124.91 | 2023-2025 | |
| Artivion, INC. | $117.15 | 2024 | On-X Aortic Heart Valve With Conform-X Sewing Ring and Extended Holder, Bioglue Surgical Adhesive, Cryovalve Sg Pulmonary Human Heart Valve |
| Sanofi-Aventis U.S. LLC | $113.11 | 2022-2024 | |
| Merck Sharp & Dohme LLC | $85.85 | 2022-2024 | Verquvo |
| Biotronik INC. | $75.64 | 2021 | |
| Esperion Therapeutics, INC. | $50.86 | 2025 | Nexletol |
| Boehringer Ingelheim Pharmaceuticals, INC. | $48.49 | 2023-2024 | Jardiance |
| Boston Scientific Corporation | $45.52 | 2021-2025 | General - Tachy |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lexicon Pharmaceuticals, INC. | $38.88 | 2023-2024 | Inpefa |
| Kiniksa Pharmaceuticals International, Plc | $38.45 | 2024 | Arcalyst |
| E.R. Squibb & Sons, L.L.C. | $33.67 | 2022-2025 | Camzyos |
| Janssen Pharmaceuticals, INC | $32.74 | 2022 | |
| Cardiva Medical, INC. | $29.91 | 2023 | Cardiva Vascade Mvp Vvcs 6-12f |
| Alnylam Pharmaceuticals INC. | $27.59 | 2024 | Amvuttra |
| Philips North America LLC | $22.29 | 2024 | (Ck7) Extended Holter |
| Endotronix, INC. | $19.39 | 2022 | |
| Kiniksa Pharmaceuticals, LTD. | $17.70 | 2023 | Arcalyst |
| Medtronic Vascular, INC. | $15.25 | 2020 | |
| Heartflow, INC. | $13.70 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Bustros listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.